Most Clicked StoriesMore >


Agency updates informed consent guidance for clinical trials

DIA Global SmartBrief | Jul 24, 2014

The FDA last week released an updated version of its informed consent guidance for clinical trials that was first issued in 1998. Among the changes in the document is the addition of a section urging studies to inform participants of the trial results. Despite the updates, several issues remain, such as a failure to discuss what should be done if participants lack the ability to consent themselves, including children, unconscious people and those who are mentally ill. MedPage Today (free registration) (07/23)


Whistleblowers to get reward for info on fake drugs in India

DIA Global SmartBrief | Jul 22, 2014

Chief of FDA's Indian office steps down

DIA Global SmartBrief | Jul 22, 2014

U.K. academia gains access to pharma's abandoned compounds

DIA Global SmartBrief | Jul 24, 2014

Shire accepts AbbVie's $55B takeover bid

DIA Global SmartBrief | Jul 22, 2014

Cuts to vital drug prices are not limited to India

DIA Global SmartBrief | Jul 24, 2014

FDA unveils application programming interface to back openFDA

DIA Global SmartBrief | Jul 24, 2014

Comments sought on EU proposal to evaluate nano-based devices

DIA Global SmartBrief | Jul 24, 2014

Phase 3 trials in Southeast Asia demonstrate efficacy of dengue vaccine

DIA Global SmartBrief | Jul 24, 2014

S. Korea invests in pharmaceutical globalization effort

DIA Global SmartBrief | Jul 24, 2014


Find DIA Global SmartBrief Issues by Date:



DIA News More >


Discounts on offer for webinar series on pediatric drug development

DIA Global SmartBrief | Jul 24, 2014

Showcase your company at 11th DIA Japan Annual Meeting

DIA Global SmartBrief | Jul 24, 2014

Learn the essentials of statistics in clinical trials

DIA Global SmartBrief | Jul 22, 2014

Get the latest updates in diagnosing and managing adverse drug reactions

DIA Global SmartBrief | Jul 22, 2014

Special discount for webinar series on clinical pharmacology in drug development

DIA Global SmartBrief | Jul 17, 2014




Sign up for DIA Global SmartBrief



Designed specifically for the global drug development professional, the DIA Global SmartBrief is a FREE, twice weekly e-mail newsletter. By providing the latest need-to-know industry news and information, the DIA Global SmartBrief saves you time and keeps you smart. Learn more